FeelGood vs GoodRx Care: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
FeelGood beats GoodRx Care overall, scoring 7/10 vs 6.2/10. GoodRx Care is more affordable at $119/mo vs $149/mo. Choose FeelGood for budget-conscious cash-pay patients who want low-cost compoun. Choose GoodRx Care for users who want fda-approved brand-name glp-1 access at marke.
A side-by-side comparison of FeelGood and GoodRx Care covering pricing, scores, medication types, insurance, and more to help you decide.
FeelGood
#48 of 49Telehealth platform offering compounded semaglutide as both a weekly injection ($149/mo starting) and a daily oral tablet ($249/mo starting), plus a premium brand-name 'original' semaglutide injection option ($1,999/mo). Cash-pay only, no insurance billing, HSA/FSA eligible. LegitScript-approved. FeelGood does not publicly disclose which states it serves, its compounding pharmacy, or its medical leadership.
Visit FeelGoodGoodRx Care
#49 of 49GoodRx Care was restructured in late 2025 from a pay-per-visit model into a telemedicine subscription: $39/mo intro rate (through January 2026) → $119/mo standard. Medication is priced aggressively: Ozempic/Wegovy $199/mo intro for the first 2 fills, then $349/mo standard. Oral Wegovy pill available at $149-199/mo.
Visit GoodRx Care| Feature | FeelGood | GoodRx Care |
|---|---|---|
| Our Score | 7/10 | 6.2/10 |
| Starting Price | $149/mo | $119/mo |
| Medication Type | Both | Brand |
| Insurance Accepted | No | Yes |
| Best For | Budget-conscious cash-pay patients who want low-cost compounded semaglutide — injection or oral tablet — with free shipping, no membership fees, and a money-back weight-loss guarantee | Users who want FDA-approved brand-name GLP-1 access at market-leading subscription pricing — $199/mo Wegovy intro, $349/mo standard, plus oral Wegovy pill |
| Ranking | #48 | #49 |
Pros & Cons Compared
FeelGood
Pros
- +Compounded semaglutide injection from $149/mo with free shipping and no separate membership or consultation fee
- +Offers an oral compounded semaglutide tablet ($249/mo) for needle-averse patients — a non-injectable route only a handful of platforms provide
- +LegitScript-approved — independent certification that the telehealth/pharmacy operation meets legal and safety standards, which many budget compounded shops lack
- +Money-back weight-loss guarantee plus unlimited 24/7 messaging and appointments included
Cons
- −Does NOT publicly disclose which US states it serves — you can't confirm availability in your state before starting an intake
- −$149 is a 'starting' price (dose-escalating), not flat across all doses — your cost can rise as your dose titrates up, and FeelGood doesn't publish the full dose-by-dose schedule
- −Brand-name 'original' semaglutide injection at $1,999/mo is far above market — NovoCare direct Wegovy is $349/mo and Hers offers Wegovy at $149/mo via the 2026 Novo Nordisk partnership. Never buy brand-name through FeelGood
- −No named medical director, prescribing physicians, compounding pharmacy, founding year, or headquarters disclosed on the site — thin corporate and clinical transparency
- −Self-reported '4.8/5' rating is not tied to a named third-party platform (no linked Trustpilot/BBB), so it can't be independently verified; the advertised '15–20% weight loss' figures are FeelGood's marketing, not FDA-reviewed efficacy data
- −Compounded GLP-1s are not FDA-approved (none are) — and FeelGood offers compounded semaglutide only, no tirzepatide
GoodRx Care
Pros
- +2026 subscription rewrite — $119/mo standard membership with medication priced among the lowest on the market
- +Wegovy/Ozempic intro pricing ($199/mo for first 2 fills) is market-leading for brand-name access
- +Oral Wegovy pill available at $149-199/mo — one of the cheapest oral semaglutide routes
- +Insurance accepted — GoodRx's integration with savings cards can stack with coverage
Cons
- −Model changed from pay-per-visit to subscription — users expecting à-la-carte pricing should double-check current terms
- −Compounded GLP-1s are de-emphasized on current marketing — may no longer be available
- −Subscription model means ongoing monthly fee even in maintenance months
- −Follow-up clinical care is still basic compared to dedicated GLP-1 platforms
Our Verdict
FeelGood edges out GoodRx Care with a score of 7/10 vs 6.2/10. If budget is your priority, GoodRx Care starts at $119/mo compared to FeelGood's $149/mo. GoodRx Care accepts insurance, which can significantly reduce your out-of-pocket costs. FeelGood offers both brand-name and compounded medications, giving you more flexibility. Choose FeelGood if you want: budget-conscious cash-pay patients who want low-cost compounded semaglutide — injection or oral tablet — with free shipping, no membership fees, and a money-back weight-loss guarantee. Choose GoodRx Care if you want: users who want fda-approved brand-name glp-1 access at market-leading subscription pricing — $199/mo wegovy intro, $349/mo standard, plus oral wegovy pill.
Still undecided? Editor's #1 Overall Pick
Embody
$299/mo · 7.3/10 · Compounded
If neither FeelGood nor GoodRx Care feels like the right fit, our overall #1 pick across all 49 GLP-1 telehealth providers is Embody — strongest balance of clinical oversight, transparent pricing, and verified availability.
Read Full Reviews
Related comparisons
Other matchups readers comparing FeelGood or GoodRx Care tend to look at next.
- FeelGood vs TMates$158/mo
- FeelGood vs Gala$149/mo
- FeelGood vs Oak Longevity$130/mo
- GoodRx Care vs Oak Longevity$130/mo
- GoodRx Care vs Ro$149/mo
- GoodRx Care vs Found$264/mo